Article

Novel accommodative IOL system may prevent PCO

A novel accommodative IOL system, teamed with an innovative capsular bag refilling technique, may be an answer to presbyopia and the prevention of posterior capsular opacification (PCO). Okihiro Nishi, MD, Nishi Eye Hospital, Osaka, Japan, introduced the concept during his presentation of the Charles D. Kelman Innovator?s Lecture.

A novel accommodative IOL system, teamed with an innovative capsular bag refilling technique, may be an answer to presbyopia and the prevention of posterior capsular opacification (PCO). Okihiro Nishi, MD, Nishi Eye Hospital, Osaka, Japan, introduced the concept during his presentation of the Charles D. Kelman Innovator's Lecture.

Dr. Nishi first described a theory of the pathogenesis of PCO in an eye receiving a sharp-edged IOL. He showed how lens epithelial cells may migrate before the capsular bend is formed by the IOL and in the case where the capsular bend formation fails.

To restore accommodation and prevent PCO, Dr. Nishi developed a dual-optic IOL system, which uses two lenses: one implanted after being inverted to seal the posterior continuous curvilinear capsulorhexis (CCC) and the other piggy-backed in the capsular bag. A silicone polymer is injected between the lenses through a hole. The lenses completely seal the CCCs and silicone cannot escape.

"The expected mechanism of accommodation occurs with forward movement of the IOL and steepening of the anterior curvature of the IOL," he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.